| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.5M | +6.7% | +19.3% |
| Cost of Revenue | $1.6M | +8.0% | +24.1% |
| Gross Profit | $1.9M | +5.7% | +15.5% |
| R&D Expense | $6.1M | +79.5% | +34.7% |
| SG&A Expense | $2.1M | +69.3% | +73.5% |
| Operating Income | -$8.0M | -72.4% | -38.2% |
| Pre-tax Income | -$7.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.9M | +0.9% | — |
| Inventory | $3.2M | +4.8% | — |
| Current Assets | $24.0M | +208.3% | — |
| Total Assets | $25.7M | +168.8% | — |
| Current Liabilities | $4.6M | +9.8% | — |
| Total Liabilities | $5.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.2M | — | — |
| Capital Expenditures | $82K | — | — |
| Investing Cash Flow | -$82K | — | — |
| Financing Cash Flow | $23.6M | — | — |
| Free Cash Flow | -$15.3M | — | — |
| -71.3% |
| -36.7% |
| Income Tax | $0 | — | — |
| Net Income | -$7.9M | -71.3% | -36.7% |
| EPS (Basic) | -$0.17 | +91.6% | +93.9% |
| EPS (Diluted) | -$0.17 | +91.6% | +93.9% |
| +6.3% |
| — |
| Stockholders' Equity | $20.4M | +114.7% | +116.4% |